Quest Diagnostics Inc. Stock
Price
Target price
€173.35
€173.35
-0.550%
-0.95
-0.550%
€173.24
09:30 / Tradegate
WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Quest Diagnostics Inc. Stock
The price for the Quest Diagnostics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.950 (-0.550%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Quest Diagnostics Inc..
On the other hand, the target price of 173 € is below the current price of 173.35 € for Quest Diagnostics Inc., so the potential is actually -0.2%.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -0.550% | 6.801% | 15.584% | 10.212% | 16.862% | 28.162% | 67.596% |
| HCA Holdings Inc. | -0.670% | 3.371% | 10.871% | 49.917% | 11.917% | 88.856% | 210.897% |
| Anthem Inc. | -0.140% | 0.390% | -11.944% | -23.734% | -3.838% | -37.443% | 18.057% |
| Universal Health Services B | 2.560% | 7.065% | 11.299% | 13.873% | 2.604% | 45.045% | 84.112% |
Comments
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat